Compare Amphastar Pharmaceuticals Inc (AMPH) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Quantum Computing Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.74 (market cap $826.08M), while Quantum Computing Inc trades at $8.47 (market cap $1.95B). The key difference: Quantum Computing Inc is far larger — about 2.4× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMPH | QUBT | |
|---|---|---|
Market Cap | $826.08M | $1.95B |
Sector | Health | Technology |
52-Week High | $30.81 | $24.62 |
52-Week Low | $16.87 | $6.31 |
Enterprise Value | $1.22B | $970.72M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Quantum Computing Inc. (QUBT) trades at $8.66, down 5.36% today, with a bearish technical outlook but strong analyst support. The company reported a net loss of $18.67 million on minimal revenue of $682,000 in 2025, reflecting high cash burn. Recent strategic acquisitions and a $10 million framework agreement with Planck Dynamics highlight growth initiatives, yet profitability remains distant amid negative margins.
QUBT offers speculative upside with a consensus price target of $24.00 (177% potential), but faces significant execution and funding risks. Investors must weigh long-term quantum technology potential against persistent losses and the need for substantial capital to survive until commercialization, making it suitable only for high-risk portfolios.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
